PAVBLU 2 mg/.05mL
aflibercept-ayyh · INJECTION, SOLUTION · Amgen, Inc
No Recall History
Plain English
PAVBLU is a injection, solution containing aflibercept-ayyh at 2 mg/.05mL, taken intravitreal. Manufactured by Amgen, Inc.
Key Facts
- Brand Name
- PAVBLU
- Generic Name
- aflibercept-ayyh
- NDC Code (Product)
55513-065- Manufacturer
- Amgen, Inc
- Strength
- 2 mg/.05mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Marketing Status
- Application #
- BLA761298
- Drug Class
- Vascular Endothelial Growth Factor Inhibitor [EPC]
- Marketing Start
- 10/28/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is PAVBLU used for?
PAVBLU contains aflibercept-ayyh. It is a injection, solution taken intravitreal. Consult your doctor for specific uses.
Is PAVBLU a controlled substance?
PAVBLU is not classified as a controlled substance by the DEA.
What is the generic name for PAVBLU?
The generic name for PAVBLU is aflibercept-ayyh. There are no other listed brand versions of aflibercept-ayyh.
What is the NDC code for PAVBLU 2 mg/.05mL?
The NDC (National Drug Code) for PAVBLU 2 mg/.05mL is 55513-065, listed by Amgen, Inc.
Other PAVBLU Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)